YILIMART - CD15 MicroBeads, human

CD15 MicroBeads were developed for positive selection or depletion of CD15

⁺

cells from human lysed peripheral blood or single-cell suspensions from tissues.

Background information

The CD15 antibody recognizes a 3-fucosyl-N-acetyllactosamine carbohydrate modification in glycolipids or glycoproteins. The CD15 antigen is expressed on neutrophils, eosinophils, and monoblastoid precursor cells of the myeloid lineage but not on basophils and lymphocytes. The antigen is also present on Hodgkin/Reed-Sternberg cells.

Downstream applications

CD15 MicroBeads are used for the isolation

¹

or depletion of human eosinophils and neutrophils (basophils are CD15

^-

) from peripheral blood and from tissues such as ovarian carcinoma tissue.

²

Furthermore, CD15 MicroBeads can be used for the depletion of myeloid cells from bone marrow.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

Figure 1

CD15

⁺

cells were isolated from lysed human peripheral blood using CD15 MicroBeads,

an MS Column, and a MiniMACS™ Separator. Cells are fluorescently stained with CD15

^-

FITC.

Unseparated fraction	CD15 ^– cells

Enriched CD15 ⁺ cells

Selected references
1. Zahler, S. et al. (1997) The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J. Immunol. Methods 200: 173-179
2. Harbeck, N. et al. (1995) Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (MACS). Int. J. Oncol. 6: 1249-1254

查看数据文件查看下载

CD15 MicroBeads, human

For research use only

您浏览过的商品

Background information

Downstream applications

Columns

Figure 1

Selected references

相关产品